BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 463.6% from a year ago
Cash & equivalents stood at $19.17M at the end of Q1 FY2026, up 463.6% from a year earlier and down 16.8% from the prior quarter. Over 3 fiscal years it compounded at +136.7% a year.
Context
- Cash & equivalents amounted to 42.1% of total assets at the end of Q1 FY2026, up 29.3 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +463.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 23.03M USD
- Year-over-year change
- +863.4%
- 4-year CAGR
- +53.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.03M | +863.4% |
| FY2024 | 2024-12-31 | 2.39M | -55.4% |
| FY2023 | 2023-12-31 | 5.36M | +208.5% |
| FY2022 | 2022-12-31 | 1.74M | -57.8% |
| FY2021 | 2021-12-31 | 4.12M | — |
Cash & Equivalents vs competitors
How BHST compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +463.6% is the 2nd highest of 8, against a peer median of -33.5%.
- Cash & equivalents amounts to 42.1% of total assets for BHST, versus a peer median of 11.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $84.54M USD | -53.4% | -19.2% | 4.3% | |
| Mar 2026 | $70.91M USD | +500.7% | -15.1% | 10.7% | |
| Mar 2026 | $47.82M USD | +235.1% | +242.0% | 46.6% | |
| Feb 2026 | CA$35.53M CAD | +253.2% | +9.7% | 16.4% | |
| Mar 2026 | $23.51M USD | -47.1% | +108.8% | 9.7% | |
| Mar 2026 | $22.37M USD | -77.0% | -33.6% | 12.5% | |
| Mar 2026 | $19.17M USD | +463.6% | +136.7% | 42.1% | |
USGOU.S. GoldMining Inc. | Feb 2026 | $4.75M USD | — | — | 66.8% |
| Mar 2026 | $2.45M USD | -33.5% | -6.4% | 0.7% | |
| Peer median (excluding BHST) | — | -33.5% | -6.4% | 11.6% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.12M | 1.74M | 5.36M | 2.39M | 23.03M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 620K | 722K | 968K | 1.34M | 2.24M |
| Inventory | 928K | 1.38M | 2.47M | 3.66M | 4.56M |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 5.67M | 4.32M | 9.05M | 7.86M | 30.5M |
| Property, Plant & Equipment (Net) | 4.36M | 4.91M | 5.77M | 16.77M | 16.73M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 179K | 163K | 179K | 371K | 433K |
| Total Non-current Assets | 4.54M | 5.07M | 5.95M | 17.15M | 17.17M |
| Total Assets | 10.21M | 9.39M | 15M | 25M | 47.67M |
| Account Payables | 875K | 1.07M | 1.78M | 3.53M | 2.63M |
| Short-term Debt | 0 | 8.55M | 20.53M | 3.91M | 149K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 394K | 836K | 1.3M | 492K |
| Other Current Liabilities | 1.33M | 698K | 1.57M | 3.66M | 2.09M |
| Total Current Liabilities | 2.92M | 11.52M | 26.47M | 14.26M | 7.68M |
| Long-term Debt | 0 | 0 | 0 | 0 | 2.42M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 1.82M | 2.01M | 0 | 0 | 0 |
| Other Non-current Liabilities | 340K | 123K | 1.96M | 272K | 1.98M |
| Total Non-current Liabilities | 4.43M | 3.8M | 3.39M | 9.41M | 14.53M |
| Total Liabilities | 7.35M | 15.32M | 29.86M | 23.67M | 22.22M |
| Common Stock | 62.56M | 65.01M | 68.65M | 97.75M | 133M |
| Retained Earnings | (59.71M) | (70.94M) | (83.51M) | (96.42M) | (107.55M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 2.86M | (5.93M) | (14.85M) | 1.33M | 25.45M |
| Total Debt | 2.66M | 10.56M | 22.34M | 13.82M | 14.1M |
| Net Debt | (1.46M) | 8.82M | 16.99M | 11.43M | (8.92M) |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.